Cleared Traditional

K151367 - Sydney IVF Hyaluronidase

K151367 is an FDA 510(k) clearance for Sydney IVF Hyaluronidase, manufactured by William A. Cook Australia Pty. , Ltd.. The device is a Class 2 Obstetrics & Gynecology device with product code MQL cleared through the Traditional 510(k) pathway after a 251-day FDA review.

K151367 · William A. Cook Australia Pty. , Ltd. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2016
Decision
251d
Days
Class 2
Risk

K151367 is an FDA 510(k) clearance for the Sydney IVF Hyaluronidase. Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by William A. Cook Australia Pty. , Ltd. (Eight Mile Plains, AU). The FDA issued a Cleared decision on January 27, 2016 after a review of 251 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all William A. Cook Australia Pty. , Ltd. devices

FDA 510(k) Submission Details - K151367

510(k) Number K151367 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 21, 2015
Decision Date January 27, 2016
Days to Decision 251 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
91d slower than avg
Panel avg: 160d · This submission: 251d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQL Device Classification - Class 2, Special Controls

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 168
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K151367.
Continuous Single Culture -NX (CSCM-NX)
K170681 · Irvine Scientific Sales Co., Inc. · Jun 2017
Continuous Single Culture-NX Complete (CSCM-NXC)
K170602 · Irvine Scientific Sales Co., Inc. · Jun 2017
SAGE Vitrification Kit and SAGE Vitrification Warming Kit
K170560 · CooperSurgical, Inc. · Apr 2017
FreezeKit Cleave , ThawKit Cleave
K150950 · Vitrolife Sweden AB · Dec 2015
SPERMFREEZE SOLUTION
K113786 · Vitrolife Sweden AB · Oct 2012
CONTINUOUS SINGLE CULTURE COMPLETE
K121572 · Irvine Scientific Sales Co., Inc. · Jul 2012